Use of pyridostigmine for the reversal of neuromuscular blockade.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000768:Anesthesia, General; D002648:Child; D003472:Curare / Q000037:antagonists & inhibitors*; D004491:Edrophonium; D004576:Electromyography; D005260:Female; D005703:Gallamine Triethiodide / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D011729:Pyridostigmine Bromide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D009467:Neuromuscular Depolarizing Agents; D009388:Neostigmine; D004491:Edrophonium; D003472:Curare; D011729:Pyridostigmine Bromide; D005703:Gallamine Triethiodide